Clinical Trial

Steroid Use in Treatment of Allergic Reactions to Food

Study acronym: SAFARI
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
In this study, the investigators want to find out whether a specific medication commonly used for severe allergic reactions is really necessary. When children have allergic reactions to foods, they are often given medications to relieve the symptoms. In addition to adrenaline and antihistamines, steroids are frequently administered in German-speaking Switzerland. However, it is unclear whether steroids are really helpful in this situation. To investigate this, the investigators are comparing two groups: one group receives additional steroids, and the other does not. Which treatment a participant receives is decided randomly, like flipping a coin. The study takes place during a pre-scheduled provocation test at the clinic. If an allergic reaction occurs, the usual emergency medications will be administered. Doctors will closely monitor how the reaction develops. No additional tests or visits are required. The results of this study could help improve allergy treatment in the future.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-07.
Status change: Not Yet Recruiting → Recruiting 2026-01-26
Trial Details
NCT Number NCT07341776
Lead Sponsor Johannes Trueck
Collaborators: University Children's Hospital Basel
Conditions Anaphylactic Reaction, Anaphylaxis, Allergy in Children, IgE Mediated Food Allergy
Enrollment 160 participants
Start Date 2026-01-26
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-27